The system will be going down for regular maintenance. Please save your work and logout.
Benefit-risk of rivaroxaban 20 or 15mg compared to vitamin-K antagonists in patients with non-valvular atrial fibrillation: a cohort study in the French nationwide claims database
Language
EN
Article de revue
This item was published in
European Heart Journal. 2018-08, vol. 39, p. 1014-1014
English Keywords
PharmacoEpi-Drugs
CIC1401